Skip to content

The Coastal Exposome: a Study of Sea Air Inhalation and Possible Links to Health

The Coastal Exposome: a Study of Sea Air Inhalation and Possible Links to Health

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06477627
Enrollment
67
Registered
2024-06-27
Start date
2024-06-19
Completion date
2026-10-31
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difference Between Coastal and Inland Populations

Keywords

Oceans and human health

Brief summary

The research aims to understand oceans as crucial contributors to human health in coastal environments. Oceans produce marine spray aerosols that contain a mixture of microbiota and natural biological molecules (biogenics).

Detailed description

The primary outcome envisioned consists of 2 goals. 1. In this study, the first objective is to determine whether the microbiota and biogenic molecules found in sea air are also found in the nasal swabs of the participants. In this way, the investigators will gain an understanding of which sea air components are inhaled by humans and how this changes over time. Besides, the difference in microbiome between the inland and coastal population will be investigated. 2. Second, the investigators want to get an idea of whether these inhaled sea air components have an effect on certain pathways in the human body. In the in vitro study with cell lines, effects were already seen of sea air exposure on certain pathways in the body. Now the second goal of this study, is to see if changes in immunity biomarkers are seen in vivo in humans. The Investigators will do this by taking VAMS blood samples from the participants.

Interventions

OTHERno intervention

no intervention, people just indicate if they spend time inland or at the coast

Sponsors

University Ghent
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

three groups: one group that lives at the coast all year round, one group that lives inland all year round and one group that live inland but spend a lot of time at the coast in the summer. The participants will not get any treatment, they just live in different regions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy participants between 18 and 50 years old

Exclusion criteria

* people with a medical condition * people younger than 18 and older than 50

Design outcomes

Primary

MeasureTime frameDescription
nose swabs: respiratory microbiome and biogenics profile4 times during the 8 week study periodDNA from the nose swabs will be analysed using sequencing for analyzing the microbiome. Biogenics on the swabs will be analysed as well, to get an idea of what molecules and microbiota from the sea air are inhaled. This will happen with UPLC-QTOF-MS.
VAMS blood samples: cytokines4 times during the 8 week study periodCytokines will be measured in blood samples to link the sea air exposure to the human health. A multiplex kit will be used to measure 20 cytokines.
GPSduring the 8 week study period, if more than 15 minutes spend outsidevia sensorlogger app on their phone, to collect GPS data when outside.
questionnairesat the start, in the middle and at the end of the 8 weeks.Filling in a questionnaire via qualtrics

Countries

Belgium

Contacts

PRINCIPAL_INVESTIGATORHannelore Denys

University Ghent

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026